Broad-led Scientists Find New Cas9 Enzyme for In Vivo CRISPR Genome Editing

Apr 01, 2015

|

NEW YORK (GenomeWeb) – The Cas9 nuclease from Staphylococcus aureus can be used to edit genomes as efficiently as Cas9 from Streptococcus pyogenes but at a smaller size, enabling CRISPR methods for in vivo applications that could eventually include therapeutic use, researchers reported today in a study published in Nature.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Open Spot

Politico notes that the Biden Administration has not yet nominated a permanent Food and Drug Administration commissioner.

US to Remain in WHO

Anthony Fauci also informed the World Health Organization executive board that the US would be joining the COVAX initiative, according to CNBC.

Dip Possible

A new preprint suggests some SARS-CoV-2 variants could affect the effectiveness of current vaccines, the Associated Press reports.

Nature Papers Examine Australian Lungfish Genome, Essential E. Coli Genes

In Nature this week: Australian lungfish provides details on the movement of vertebrate life from water to land, and more.

Featured White Papers

Efficient DNA Extractions for CRISPR Toolkits

Compatibility of Liquid Biopsy Assays on Multiple Sequencing Platforms

Sequencing the Unsequenceable: FFPE Sample Processing for Successful Target Enrichment

CAS-CLOVER The clean alternative to CRISPR/Cas9 for gene editing in the drug discovery and development industry

Jan

26

Featured Webinar

Panel Discussion: Genotyping by Sequencing for Novel SNP Discovery with Less Common Genomes

Reduced representation next-generation sequencing (NGS) methods are driving understanding of both physical and structural variation in all species.

Feb

18

Featured Webinar

Single-Cell Multiomics to Elucidate Immune Alterations in the Human Tumor Microenvironment

The composition of the immune infiltrate in the human tumor microenvironment is a critical determinant of disease progression.

Feb

23

Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before.

Mar

11

Featured Webinar

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

In this session, the third in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified gene fusions that may or may not serve as druggable targets.

Menu

Broad-led Scientists Find New Cas9 Enzyme for In Vivo CRISPR Genome Editing

To read the full story....

Breaking News

Fluidigm Obtains CE Mark for Saliva-Based SARS-CoV-2 Assay

Skin Cell Atlas Elucidates Pathological Cell States Underlying Inflammatory Skin Diseases

Lung Cancer Metastasis Study Relies on CRISPR-Based Method to Track Single-Cell Lineages

Breast Cancer Risk Gene Associations Refined in Large-Scale Studies

Genetic Technologies to Raise $6.6M in Direct Offering

CareDx Prices $175M Common Stock Offering

The Scan

Open Spot

US to Remain in WHO

Dip Possible

Nature Papers Examine Australian Lungfish Genome, Essential E. Coli Genes

Featured White Papers

Panel Discussion: Genotyping by Sequencing for Novel SNP Discovery with Less Common Genomes

Single-Cell Multiomics to Elucidate Immune Alterations in the Human Tumor Microenvironment

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

What's Popular?

Mammoth Biosciences Taking Lead Role in DARPA-Funded Development of Pathogen Detection Tech

Lung Cancer Metastasis Study Relies on CRISPR-Based Method to Track Single-Cell Lineages

Sponsorships